High-dose Botulinum Toxin Therapy: Safety, Benefit, and Endurance of Efficacy

BACKGROUND: Botulinum neurotoxin therapy (BoNT) is a powerful tool for treating many neurologic disorders. The U.S. Food and Drug Administration (FDA)-approved maximum onabotulinum toxin A (OnaA) dose is 400 units (U) per visit, but higher doses are commonly necessary, particularly when treating mul...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiu, Shannon Y., Patel, Bhavana, Burns, Matthew R., Legacy, Joseph, Wagle Shukla, Aparna, Ramirez-Zamora, Adolfo, Deeb, Wissam, Malaty, Irene A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Columbia University Libraries/Information Services 2020
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052428/
https://www.ncbi.nlm.nih.gov/pubmed/32149014
http://dx.doi.org/10.7916/tohm.v0.749

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052428/
https://www.ncbi.nlm.nih.gov/pubmed/32149014
http://dx.doi.org/10.7916/tohm.v0.749

Ejemplares similares